Clinical Trial Update: Efficacy and Safety of Repaglinide and Metformin Combined in Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy and safety of combining repaglinide with metformin in adults with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Repaglinide (Repaglinide)
• metformin (metformin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED